Clinical Trials
47 trialsTissue Acquisition and Genomics Analysis of Breast Cancer and Other Gynecologic Malignancies
National Institutes of Health Clinical Center (CC)
Gene Therapy Follow up Protocol for Subjects Previously Enrolled in NCI Center for Immuno-Oncology Studies
National Institutes of Health Clinical Center (CC)
Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer
National Institutes of Health Clinical Center (CC)
National Cancer Institute "Cancer Moonshot Biobank"
National Cancer Institute (NCI)
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
National Institutes of Health Clinical Center (CC)
Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk
National Institutes of Health Clinical Center (CC)
Predictors of Relapse of Ovarian, Peritoneal, and Fallopian Tube Cancers
National Institutes of Health Clinical Center (CC)
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
National Institutes of Health Clinical Center (CC)
Extended Follow Up of Young Women in Costa Rica Who Received Vaccine for Human Papillomavirus Types 16 and 18 and Unvaccinated Controls
National Cancer Institute (NCI)
Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study
National Cancer Institute (NCI)
Collection of Malignant Ascites, Pleural Fluid, and Blood From People With Solid Tumors
National Institutes of Health Clinical Center (CC)
Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With Cancer to Study Drug Resistance
National Institutes of Health Clinical Center (CC)
A Follow-up Study of Women Evaluated and Treated for Infertility
National Institutes of Health Clinical Center (CC)
Follow-up Protocol for Patients With Cancer/AIDS/Skin Disease
National Institutes of Health Clinical Center (CC)
Blood Collection From People With Ovarian Cancer
National Institutes of Health Clinical Center (CC)
Assessment of Screening Modalities for Gynecologic Cancers
National Institutes of Health Clinical Center (CC)
Endometrial Cancer Testing With Vaginal and Endometrial Cell Samples
National Institutes of Health Clinical Center (CC)
Continuation of Follow-up of DES-Exposed Cohorts
National Institutes of Health Clinical Center (CC)
Improving Cervical Cancer Screening Among HIV-Infected Women in India
National Institutes of Health Clinical Center (CC)
Extended Follow-up of Columbia, MO Serum Bank Participants
National Institutes of Health Clinical Center (CC)
Preliminary Study of Endometrial Hyperplasia Groundwork for a Study to Define Precursors of Endometrial Cancer
National Institutes of Health Clinical Center (CC)
Molecular Staging of Endometrial Cancer
National Institutes of Health Clinical Center (CC)
Human Papillomavirus (HPV) and Risk of Cervical Precancer and Cancer
National Institutes of Health Clinical Center (CC)
Cervix Image Sharing Protocol (CISP)
National Institutes of Health Clinical Center (CC)
Breast Cancer in Poland: An Expanded Study to Assess Occupational and Environmental Factors and Interactions With Genetics
National Institutes of Health Clinical Center (CC)
Bone Mineral Density and Subsequent Cancer Risk
National Institutes of Health Clinical Center (CC)
Cervical Cancer Early Endpoints and Determinants
National Institutes of Health Clinical Center (CC)
A Pilot Study of a Protein Profile Test in Ovarian Cancer Patients in Remission to See if Protein Changes Can Predict Relapse (be Predictive of Cancer Relapse)
National Institutes of Health Clinical Center (CC)
Family Communication of Hereditary Breast and Ovarian Cancer Risk Among African Americans
National Institutes of Health Clinical Center (CC)
Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial
National Institutes of Health Clinical Center (CC)
Human Papillomavirus (HPV) Testing to Improve Cervical Cancer Screening in the Mississippi Delta
National Institutes of Health Clinical Center (CC)
Microarray Analysis for Human Genetic Disease
National Institutes of Health Clinical Center (CC)
PCOS Twin Study - Environmental Factors in the Development of Polycystic Ovary Syndrome, Phase 2
National Institutes of Health Clinical Center (CC)
A Comparison Study of Two Community Outreach-Based Approaches to Increase Participation of Women Living in the Mississippi Delta in Cervical Cancer Screening
National Institutes of Health Clinical Center (CC)
Low-Cost Molecular Cervical Cancer Screening Study
National Institutes of Health Clinical Center (CC)
Study of Physical and Psychosocial Rehabilitation Needs of Patients After Diagnosis and Treatment of Upper Gastrointestinal Cancer or Gynecological Cancer
National Cancer Institute (NCI)
Laboratory Study in Predicting Tumor Response to Chemotherapy in Patients With Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
National Cancer Institute (NCI)
Study of Genes and the Environment in Patients With Ovarian Cancer in the East Anglia, Oxford, Trent, or West Midlands Regions of the United Kingdom
National Cancer Institute (NCI)
Study of Genes and the Environment in Patients With Endometrial Cancer in the East Anglia, Oxford, Trent, or West Midlands Regions of the United Kingdom
National Cancer Institute (NCI)
Treatment Outcome and Quality of Life in Patients With Pediatric Extra-Cranial Germ Cell Tumors Previously Treated on Clinical Trial CCLG-GC-1979-01 or CCLG-GC-1989-01
National Cancer Institute (NCI)
Role of Biomarkers in Endometrial Cancer Recurrence in Samples From Patients With Stage II, Stage III, or Stage IV Endometrial Cancer
National Cancer Institute (NCI)
Study of Pap Smears From Patients Enrolled on Clinical Trial GOG-171
National Cancer Institute (NCI)
Biomarkers in Tissue Samples From Patients With Stage I or Stage III Endometrial Cancer
National Cancer Institute (NCI)
Biomarkers in Predicting Response in Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Treated on GOG-0172 or GOG-0182
National Cancer Institute (NCI)
Studying Biomarkers in Blood Samples From Patients With Invasive Cervical Cancer
National Cancer Institute (NCI)
Environmental Factors in the Development of Polycystic Ovary Syndrome
National Institutes of Health Clinical Center (CC)
Outcomes of Education and Counseling for BRCA1 Testing
National Institutes of Health Clinical Center (CC)